Related Experiment Video

Updated: Sep 21, 2025

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

12.9K

Selfish antibodies target auto-antigens in cancer

Ángel Garza Reyna1, Gabriel K Griffin1,2

  • 1Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Science Immunology
|June 3, 2022
PubMed

Insights

Auto-antibodies targeting matrix metalloproteinase-14 (MMP14) indicate tumor-specific immune responses in ovarian cancer patients. This discovery offers potential new avenues for diagnosing and treating this disease.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Ovarian cancer is a leading cause of cancer-related death in women.
  • Identifying tumor-specific immune responses is crucial for developing effective immunotherapies.
  • Matrix metalloproteinase-14 (MMP14) is implicated in tumor progression and metastasis.

Purpose of the Study:

  • To investigate the presence and significance of auto-antibodies against MMP14 in ovarian cancer patients.
  • To determine if these auto-antibodies correlate with tumor-reactive humoral immunity.

Main Methods:

  • Immunoassays (e.g., ELISA) were used to detect auto-antibodies against MMP14 in patient serum.
  • Patient cohorts included ovarian cancer patients and healthy controls.
  • Correlation analysis was performed between auto-antibody levels and clinical parameters.

Main Results:

  • Auto-antibodies against MMP14 were significantly elevated in ovarian cancer patients compared to controls.
  • The presence of these auto-antibodies suggests a humoral immune response directed against MMP14-expressing tumors.
  • MMP14 auto-antibody levels showed potential correlation with disease stage.

Conclusions:

  • Auto-antibodies against MMP14 serve as biomarkers for tumor-reactive humoral responses in ovarian cancer.
  • Targeting MMP14 or modulating the associated immune response could be a therapeutic strategy.
  • Further research is warranted to explore the diagnostic and therapeutic potential of MMP14 auto-antibodies.

More Related Videos

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

9.1K
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
686
Cross-reactivity00:42

Cross-reactivity

Overview
31.6K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
620
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
705